HIV News and Research

RSS

Study shows how deadly Candida albicans might be rendered harmless

Candida albicans is a double agent: In most of us, it lives peacefully, but for people whose immune systems are compromised by HIV or other severe illnesses, it is frequently deadly. Now a new study from Johns Hopkins and Harvard Medical School shows how targeting a specific fungal component might turn the fungus from a lion back into a kitten.

25 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, for the first time, allow individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.

24 Sep 2013

Discovery could help develop new treatments for blood diseases

Researchers in Melbourne, Australia, have found that even our immune system is subject to performance enhancement, with our bodies giving immune cells the boost they need to ensure the best team is selected to fight infections.

24 Sep 2013

EcoHealth Alliance to study land use alteration in disease emergence, climate change in Asia

EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the award of a three-year, $2 million award to address land use alteration as a significant driver of both disease emergence and climate change in Asia.

24 Sep 2013

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

The topical anti-fungal drug Ciclopirox causes HIV-infected cells to commit suicide by jamming up the cells' powerhouse, the mitochondria—according to a study by researchers at Rutgers New Jersey Medical School. And unlike current anti-HIV drugs, Ciclopirox completely eradicates infectious HIV from cell cultures, with no rebound of virus when the drug is stopped.

24 Sep 2013

HP launches new CDC-recognized Diabetes Prevention Program for Bronx residents

Health People (HP) announced today the launch of its new Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program for Bronx residents to help the borough combat its high diabetes-related death rate - the highest in the city.

23 Sep 2013

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (elvitegravir fixed combination, trade name: Stribild) has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 (HIV-1).

21 Sep 2013

Antibody that binds, neutralizes HIV likely also targets the body's own self proteins

Researchers at The Scripps Research Institute discovered that an antibody that binds and neutralizes HIV likely also targets the body's own "self" proteins. This finding could complicate the development of HIV vaccines designed to elicit this protective antibody, called 4E10, and others like it, as doing so might be dangerous or inefficient.

20 Sep 2013

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Working with cells in test tubes and in mice, researchers at Johns Hopkins have discovered that a chemical commonly used as a dog food preservative may prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol.

20 Sep 2013

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

Pinning down an effective way to combat the spread of the human immunodeficiency virus, the viral precursor to AIDS, has long been challenge task for scientists and physicians, because the virus is an elusive one that mutates frequently and, as a result, quickly becomes immune to medication.

20 Sep 2013

Only few service providers are available to help young gay black men, say researchers

Physical, sexual and emotional abuse among young gay black men is a pervasive problem, yet there remains a lack of social services and resources available to help them, a Michigan State University scholar argues in a new study.

19 Sep 2013

Study: Neurocognitive impairment is one of common side effects of HIV and AIDS

One of the common side effects of HIV and AIDS is neurocognitive impairments - changes in how fast a person can process information, pay attention, multi-task and remember things - yet there are no adequate tests to screen patients for these problems, according to a new study out of St. Michael's Hospital.

19 Sep 2013

School of Public Health professor gets NIH grant to study alcohol use among African youth acquiring HIV

Dr. Monica Swahn, professor in the School of Public Health and associate vice president for research at Georgia State University, has received a two-year, $390,000 grant from the National Institutes of Health to study the role of alcohol marketing and early alcohol use among African youth acquiring HIV.

19 Sep 2013

New gonorrhea treatment eliminates gonococcal infection from female mice

A new gonorrhea treatment, based on an anti-cancer therapy developed by a Buffalo startup company, has successfully eliminated gonococcal infection from female mice and prevented reinfection, according to research published today by University at Buffalo scientists in the Journal of Infectious Diseases.

19 Sep 2013

Researchers discover new way to combat HIV-1 infection

Current drug treatments for HIV work well to keep patients from developing AIDS, but no one has found a way to entirely eliminate the virus from the human body, so patients continue to require lifelong treatment to prevent them from developing AIDS.

19 Sep 2013

Scientists develop experimental vaccine against human CMV infection

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more effective than previous vaccines developed to prevent infection by the ubiquitous virus.

19 Sep 2013

Researchers identify new gene that may have ability to prevent HIV

A team of researchers led by King's College London has for the first time identified a new gene which may have the ability to prevent HIV, the virus that causes AIDS, from spreading after it enters the body.

19 Sep 2013

Innovative platform improves diagnostics and detection of biomolecules

Separating target molecules in biological samples is a critical part of diagnosing and detecting diseases. Usually the target and probe molecules are mixed and then separated in batch processes that require multiple pipetting, tube washing and extraction steps that can affect accuracy.

18 Sep 2013

Researchers identify starting points for preventing diarrheal disease outbreaks in remote Africa

Using a simple survey tool, a team of researchers has done what complex studies have failed to do -- provide data that identifies starting points for preventing diarrheal disease outbreaks in at least one region of Africa.

18 Sep 2013

HIV News and Research

Study shows how deadly Candida albicans might be rendered harmless

Quartette tablets now available in U.S. for prevention of pregnancy

JPM, Bill & Melinda Gates Foundation announces capital raise for first-of-its-kind investment product

Discovery could help develop new treatments for blood diseases

EcoHealth Alliance to study land use alteration in disease emergence, climate change in Asia

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

HP launches new CDC-recognized Diabetes Prevention Program for Bronx residents

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

Antibody that binds, neutralizes HIV likely also targets the body's own self proteins

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

Only few service providers are available to help young gay black men, say researchers

Study: Neurocognitive impairment is one of common side effects of HIV and AIDS

School of Public Health professor gets NIH grant to study alcohol use among African youth acquiring HIV

New gonorrhea treatment eliminates gonococcal infection from female mice

Researchers discover new way to combat HIV-1 infection

Scientists develop experimental vaccine against human CMV infection

Researchers identify new gene that may have ability to prevent HIV

Innovative platform improves diagnostics and detection of biomolecules

Researchers identify starting points for preventing diarrheal disease outbreaks in remote Africa

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News